David H. Holman

1.3k total citations
21 papers, 1.0k citations indexed

About

David H. Holman is a scholar working on Molecular Biology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David H. Holman has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Infectious Diseases and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David H. Holman's work include Viral Infections and Vectors (8 papers), Viral Infections and Outbreaks Research (7 papers) and Sphingolipid Metabolism and Signaling (6 papers). David H. Holman is often cited by papers focused on Viral Infections and Vectors (8 papers), Viral Infections and Outbreaks Research (7 papers) and Sphingolipid Metabolism and Signaling (6 papers). David H. Holman collaborates with scholars based in United States, United Kingdom and Canada. David H. Holman's co-authors include John Y. Dong, Danher Wang, Jan Woraratanadharm, Min Luo, James S. Norris, Saeed Elojeimy, Ahmed El‐Zawahry, Yusuf A. Hannun, William D. Pratt and Alicja Bielawska and has published in prestigious journals such as Journal of Virology, FEBS Letters and Vaccine.

In The Last Decade

David H. Holman

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David H. Holman United States 18 499 408 204 184 125 21 1.0k
Antonella Pasquato Switzerland 19 265 0.5× 454 1.1× 151 0.7× 76 0.4× 112 0.9× 45 981
Marceline Côté Canada 17 345 0.7× 723 1.8× 338 1.7× 122 0.7× 121 1.0× 51 1.3k
Jorge Martı́n United States 23 545 1.1× 280 0.7× 72 0.4× 321 1.7× 263 2.1× 42 1.1k
Elena Bekerman United States 9 226 0.5× 261 0.6× 132 0.6× 187 1.0× 34 0.3× 9 763
Valérie Maréchal France 14 375 0.8× 564 1.4× 323 1.6× 122 0.7× 162 1.3× 18 1.4k
Sumana Chandramouli United States 17 373 0.7× 189 0.5× 434 2.1× 95 0.5× 78 0.6× 28 968
Eugene V. Barsov United States 15 485 1.0× 203 0.5× 204 1.0× 46 0.3× 212 1.7× 28 1.1k
Bernadette Ferraro United States 14 460 0.9× 230 0.6× 155 0.8× 162 0.9× 64 0.5× 18 1.1k
S. Gurusiddappa United States 10 453 0.9× 268 0.7× 65 0.3× 198 1.1× 35 0.3× 16 743
Agnes E. Hamburger United States 13 287 0.6× 108 0.3× 115 0.6× 74 0.4× 46 0.4× 19 769

Countries citing papers authored by David H. Holman

Since Specialization
Citations

This map shows the geographic impact of David H. Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Holman more than expected).

Fields of papers citing papers by David H. Holman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Holman. The network helps show where David H. Holman may publish in the future.

Co-authorship network of co-authors of David H. Holman

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Holman. A scholar is included among the top collaborators of David H. Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Holman. David H. Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pratt, William D., Danher Wang, Donald K. Nichols, et al.. (2010). Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector. Clinical and Vaccine Immunology. 17(4). 572–581. 80 indexed citations
2.
Holman, David H., Adam Penn‐Nicholson, Danher Wang, et al.. (2009). A Complex Adenovirus-Vectored Vaccine against Rift Valley Fever Virus Protects Mice against Lethal Infection in the Presence of Preexisting Vector Immunity. Clinical and Vaccine Immunology. 16(11). 1624–1632. 34 indexed citations
3.
Swenson, Dana L., Danher Wang, Min Luo, et al.. (2008). Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections. Clinical and Vaccine Immunology. 15(3). 460–467. 102 indexed citations
4.
Holman, David H., Danher Wang, Nicholas U. Raja, et al.. (2008). Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine. 26(21). 2627–2639. 36 indexed citations
5.
Raviprakash, Kanakatte, Danher Wang, Dan Ewing, et al.. (2008). A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus. Journal of Virology. 82(14). 6927–6934. 94 indexed citations
6.
Elojeimy, Saeed, Xiang Liu, John McKillop, et al.. (2007). Role of Acid Ceramidase in Resistance to FasL: Therapeutic Approaches Based on Acid Ceramidase Inhibitors and FasL Gene Therapy. Molecular Therapy. 15(7). 1259–1263. 81 indexed citations
7.
Holman, David H., Lorianne S. Turner, Ahmed El‐Zawahry, et al.. (2007). Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells. Cancer Chemotherapy and Pharmacology. 61(2). 231–242. 73 indexed citations
8.
Luo, Min, Danher Wang, Jason A. Wicker, et al.. (2007). Complex Adenovirus-Mediated Expression of West Nile Virus C, PreM, E, and NS1 Proteins Induces both Humoral and Cellular Immune Responses. Clinical and Vaccine Immunology. 14(9). 1117–1126. 25 indexed citations
9.
Raja, Nicholas U., David H. Holman, Kanakatte Raviprakash, et al.. (2007). INDUCTION OF BIVALENT IMMUNE RESPONSES BY EXPRESSION OF DENGUE VIRUS TYPE 1 AND TYPE 2 ANTIGENS FROM A SINGLE COMPLEX ADENOVIRAL VECTOR. American Journal of Tropical Medicine and Hygiene. 76(4). 743–751. 20 indexed citations
10.
Norris, James S., Alicja Bielawska, Terry A. Day, et al.. (2006). Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report. Cancer Gene Therapy. 13(12). 1045–1051. 56 indexed citations
11.
Liu, Xiang, Youssef H. Zeidan, Saeed Elojeimy, et al.. (2006). Involvement of Sphingolipids in Apoptin-Induced Cell Killing. Molecular Therapy. 14(5). 627–636. 23 indexed citations
12.
Elojeimy, Saeed, John McKillop, Ahmed El‐Zawahry, et al.. (2006). FasL gene therapy: a new therapeutic modality for head and neck cancer. Cancer Gene Therapy. 13(8). 739–745. 32 indexed citations
13.
Liu, Xiang, Saeed Elojeimy, Ahmed El‐Zawahry, et al.. (2006). Modulation of Ceramide Metabolism Enhances Viral Protein Apoptin's Cytotoxicity in Prostate Cancer. Molecular Therapy. 14(5). 637–646. 50 indexed citations
14.
Elojeimy, Saeed, David H. Holman, Xiang Liu, et al.. (2006). New insights on the use of desipramine as an inhibitor for acid ceramidase. FEBS Letters. 580(19). 4751–4756. 92 indexed citations
15.
Norris, James S., Kristi L. Norris, David H. Holman, et al.. (2005). The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neck. Future Oncology. 1(1). 115–123. 11 indexed citations
16.
Li, Jin Zhong, David H. Holman, Hongwei Li, et al.. (2005). Long‐term tracing of adenoviral expression in rat and rabbit using luciferase imaging. The Journal of Gene Medicine. 7(6). 792–802. 11 indexed citations
17.
Wang, Danher, Alan Schmaljohn, Nicholas U. Raja, et al.. (2005). De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses. Vaccine. 24(15). 2975–2986. 23 indexed citations
18.
Sudarshan, Sunil, David H. Holman, Marc L. Hyer, et al.. (2004). In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer. Cancer Gene Therapy. 12(1). 12–18. 35 indexed citations
19.
Sasaki, Tsutomu, David H. Holman, Brian J. Beres, et al.. (2003). Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Therapy. 10(20). 1735–1743. 114 indexed citations
20.
Li, Jin Zhong, Hongwei Li, David H. Holman, et al.. (2003). Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenoviruses. Molecular Therapy. 8(5). 822–829. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonella Pasquato Breakdown of academic impact, for papers by Marceline Côté Breakdown of academic impact, for papers by Jorge Martı́n Breakdown of academic impact, for papers by Elena Bekerman Breakdown of academic impact, for papers by Valérie Maréchal Breakdown of academic impact, for papers by Sumana Chandramouli Breakdown of academic impact, for papers by Eugene V. Barsov Breakdown of academic impact, for papers by Bernadette Ferraro Breakdown of academic impact, for papers by S. Gurusiddappa Breakdown of academic impact, for papers by Agnes E. Hamburger
Rankless by CCL
2026